Duration of prednisone administration in the PDN arm
| . | N . | Median duration, wk (range) . |
|---|---|---|
| Overall | 97 | 11 (2-161) |
| 1-3 mo | 59 | |
| 4-12 mo | 30 | |
| >12 mo | 8 | |
| Initial responders discontinuing prednisone* | ||
| Within 3 mo of follow-up | 25 | 8 (6-16) |
| 4-6 mo of follow-up | 9 | 23 (18-29) |
| 7-12 mo of follow-up | 7 | 43 (33-51) |
| . | N . | Median duration, wk (range) . |
|---|---|---|
| Overall | 97 | 11 (2-161) |
| 1-3 mo | 59 | |
| 4-12 mo | 30 | |
| >12 mo | 8 | |
| Initial responders discontinuing prednisone* | ||
| Within 3 mo of follow-up | 25 | 8 (6-16) |
| 4-6 mo of follow-up | 9 | 23 (18-29) |
| 7-12 mo of follow-up | 7 | 43 (33-51) |
These numbers did not include patients who discontinued prednisone because of a loss of response.